Printed from Voxsanity (voxsanity.com.au) — NCT07642024 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Lung Cancer
Phase 3 Lung Cancer Trial, Recruiting
NCT07642024
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are willing to give their informed consent and agree to follow the study requirements.
- People aged 18 to 75 years, of any gender.
- People with an expected survival time of at least 3 months.
- People who have been diagnosed with non-small cell lung cancer (a common type of lung cancer).
- People whose tumor tissue has been tested and shows one of the specific EGFR gene changes (mutations) that the trial is looking for.
- People who are able to provide either a stored tumor tissue sample taken within the past 12 months, or a fresh tissue sample.
- People who have had a breathing (lung function) test done within 28 days before starting the trial treatment.
- People who are largely able to carry out daily activities, with little or no limitation due to their illness (confirm with trial site for exact scoring details).
- People who do not have severe heart problems.
- People whose liver, kidney, and blood function results meet the levels required by the trial (confirm with trial site for exact values).
- People whose urine protein levels are within the acceptable range set by the trial.
- Women who could become pregnant must have a negative blood pregnancy test within 7 days before starting treatment, must not be breastfeeding, and all participants must use reliable contraception throughout treatment and for 7 months after treatment ends.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a type of lung cancer called small cell lung cancer (SCLC), a mix of small cell and non-small cell lung cancer, or any other lung cancer type that is not non-small cell.
- People who go on to have only a small portion of the lung removed (segmentectomy or wedge resection) rather than a larger surgical procedure.
- People who are assessed by the trial centre's surgical team as not being suitable for surgery.
- People who have had major surgery within the 4 weeks before starting the trial treatment.
- People who have previously received other systemic cancer treatments for their non-small cell lung cancer outside of what this trial involves.
- People who have been taking high-dose steroid tablets (prednisone above 10 mg per day) long-term within the 2 weeks before joining the trial.
- People with a history of serious heart disease or stroke-related (cerebrovascular) disease.
- People with certain heart rhythm abnormalities, such as a prolonged QTc interval or complete left bundle branch block (confirm with trial site for full details).
- People who have had a blood clot event within the 6 months before screening.
- People with known or suspected scarring or inflammation of the lung tissue (interstitial lung disease).
- People who have been diagnosed with another active cancer within the 5 years before joining the trial.
- People whose high blood pressure has not been adequately controlled despite taking two blood pressure medications.
- People with poorly controlled blood sugar levels.
- People who have had a serious infection within the 4 weeks before joining the trial.
- People who have a large build-up of fluid in body cavities, or fluid causing symptoms (confirm with trial site for full details).
- People whose scans show the cancer has grown into or wrapped around major structures in the chest or abdomen (confirm with trial site for full details).
- People who have had a serious wound, ulcer, or broken bone that has not healed within the 4 weeks before signing the consent form.
- People who have had significant bleeding or a clear tendency to bleed within the 4 weeks before signing the consent form.
- People with inflammatory bowel disease, a history of having a large portion of the bowel removed, or a history of immune-related bowel inflammation.
- People with a known allergy to the study drug or related substances.
- People who have had a solid organ transplant, or a bone marrow or stem cell transplant.
- People who test positive for HIV, have an active hepatitis B infection, or have a hepatitis C infection.
- People with a history of serious neurological or psychiatric conditions.
- People who have received, or are planning to receive, a live vaccine within the 28 days before joining the trial.
- People who have other medical conditions or circumstances that the trial doctor considers would make participation unsuitable.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Contact this trial
Phone: 15013238943
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Phase 3
Sponsor
Sichuan Baili Pharmaceutical Co., Ltd.
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 December 2032
Where this trial is recruiting
🇨🇳 China
Primary endpoints
Major Pathological Response (MPR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.